Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Evaluating credit card rewards is crucial for maximizing value. Learn which options provide the best returns for your spending.
28,180 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
Netflix moves to acquire Ben Affleck's AI startup for up to $600 million, signaling a rapid shift from internal tool-...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
A dramatic intraday surge in Plug Power stock highlighted the day’s market mood. This article unpacks the catalysts b...
What could happen to NuScale Power stock over the next five years? This article breaks down the catalysts, scenarios,...
HouseWhisper unveils two AI-powered tools that automate outreach and lead routing for real estate teams. The update t...
Intel stock crashed week as three pressures converged, turning a rally into a sharp pullback. This article breaks dow...
Philanthropy headlines are buzzing as Warren Buffett shifts a long-standing gift pattern. This piece breaks down what...
Daylight Saving Time can spike stress for households, and money worries often follow. This guide explains why anxiety...
The SEC will host an April roundtable on options market structure, focusing on how bitcoin exposure sits inside regul...
Markets react to renewed talks on extending an Iran ceasefire, with potential sanctions relief and Oil-flow changes o...